Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel - News-Medical.Net

The spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) over the whole world, causing successive waves of coronavirus disease 2019 (COVID-19), has led to intensive research int… [+7123 chars] The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences. Read More